CIK 0001622229
- Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 465308248
- Phone
- +1 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +17,901 | 17,901 | ||
| 2025-06-04 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +44,700 | 44,700 | ||
| 2024-06-05 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +44,700 | 44,700 | ||
| 2023-06-07 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +36,700 | 36,700 | ||
| 2022-06-07 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +30,700 | 30,700 | ||
| 2021-03-11 | Harwin Peter Evan Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-08-27 | Harwin Peter Evan Director | Grant or award · Director Stock Option (Right to Buy) | +28,661 | 28,661 |
Page 1 of 1 · 7 trades